A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma - Mattei, Jane; Ballhausen, Alexej; Bassett, Roland; Shephard, Michael; Chattopadhyay, Chandrani; Hudgens, Courtney; Tetzlaff, Michael; Woodman, Scott; Sato, Takami; Patel, Sapna P. (Melanoma research, 2020)
Gesehen am 04.02.2021